Latvian Minister of Health Ingrīda Circene visits JSC Grindeks

Category: News

Latvian Minister of Health Ingrīda Circene visits JSC Grindeks

JSC Grindeks informs that Grindeks today, on 1 March, was visited by the Latvian Minister of Health Ingrīda Circene, who met with the management representatives...
01/03/2012

On Grindeks financial results for 2011

Today, on 24 February, JSC Grindeks has submitted the non-audited consolidated financial statements for 2011 to “Nasdaq OMXRiga”. Non-audited financial results show that the turnover...
24/02/2012

Grindeks: EU-funded Competence Centres Program is important to the development of Latvia’s national economy

JSC Grindeks informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence...
07/02/2012

JSC Grindeks Foundation “For the Support of Science and Education” awards premiums to teachers, higher educational institutions` teaching staff and educational institutions

JSC Grindeks Foundation “For the Support of Science and Education” informs thatt oday, on 29 December, it has awarded teachers, higher educational institutions` teaching staff...
29/12/2011

JSC Grindeks original preparation Mildronate® GX recognised as “The Cardiological Medication of the Year” in Ukraine

The original preparation Mildronate® GX of Grindeks has received the prestigious award and nomination “The Cardiological Medication of the Year” in the awarding ceremony of...
03/10/2011

Grindeks will participate in the exhibition „CPhI Worldwide 2011”

From October 25 to 27, JSC Grindeks will participate in the international exhibition “CPhI Worldwide 2011” in Messe Frankfurt, Germany. During the exhibition Grindeks will...
21/09/2011

Grindeks invites media to opening ceremony of UDCA manufacturing unit on 16 June 2011

Active pharmaceutical ingredients UDCA* manufacturing unit is one of Grindeks most significant investment projects. The total contribution of the new manufacturing unit consists of 6.34...
13/06/2011

Grindeks vitamins return in packaging developed by students of Art Academy of Latvia

Grindeks informs that starting this autumn in Latvian pharmacies will once again be offered the company`s manufactured vitamins. Vitamin Gritamin® series will have six products...
10/06/2011

Representatives of European Commission, Latvian Investment and Development Agency and Latvian Finance Ministry visit JSC Grindeks

JSC Grindeks informs that today, on 29 March, the company is visited by the representatives of the European Commission, the Latvian Investment and Development Agency...
29/03/2011

Grindeks establishes new anti-cancer manufacturing unit

Joint-stock company Grindeks informs that it has established a new anti-cancer final dosage forms’ manufacturing unit, in which 400 thousand lats have been invested. Production...
04/02/2011

Grindeks successfully continues registration of Mildronate® in China

JSC Grindeks informs that the company successfully continues registration of Mildronate® in the People’s Republic of China. Last week in China, Beijing Grindeks management representatives...
27/01/2011

Grindeks receives the award for the Best Investor Relations Online in the Baltic countries and the Best Investor Relations in Latvia

On 20 January 2010 in the annual “Baltic Market Awards” ceremony of the Stock Exchange “Nasdaq OMX Riga” Grindeks was awarded for the Best Investor...
21/01/2011

On development of JSC Grindeks Group

JSC Grindeks informs that, reviewing the Group’s further development, manufacturing plant establishment in Russia is being considered as one of the options. No decisions have...
29/12/2010

Grindeks won the prize “Leading Exporter”

On 9 December 2010 in the contest “Export and Innovation Award 2010” organized by the Ministry of Economics of the Republic of Latvia and Investment...
12/12/2010

Profit of Grindeks in the first nine months of 2010 – 5.2 million lats

Today, on 26 November the financial statements of the JSC Grindeks on the first nine months of the year 2010 submitted to “NASDAQ OMX Riga”...
26/11/2010
1 10 11 12 13 14 16
magnifiercrossmenu